Core Viewpoint - Klotho Neurosciences Inc. has announced the acquisition of Greenland Mines Corp., which significantly enhances its resource portfolio with valuable palladium and gold deposits [1][2]. Group 1: Acquisition Details - Klotho Neurosciences will now operate under two strategic divisions: Natural Resources, focusing on the Skaergaard Project, and Cell and Gene Therapy [5]. - The acquisition will be executed through convertible preferred stock, resulting in Greenland Mines holding approximately 93% of the new entity [7]. Group 2: Resource Valuation - Greenland Mines controls an 80% interest in the Skaergaard Project, which is one of the largest undeveloped palladium, gold, and platinum deposits, valued at approximately $68 billion based on February 2026 metal prices [2][3]. - The Skaergaard Project hosts 25.4 million ounces of palladium equivalent (PdEq) and 23.5 million ounces of gold equivalent (AuEq) [3]. Group 3: Future Outlook - The company believes the current resource estimate does not fully represent the potential of the Skaergaard deposit, which remains open in all directions, with ongoing drilling campaigns yielding positive results [4]. - Klotho's leadership will remain in place post-acquisition, with the Greenland Mines leadership team joining to manage the new division [6].
Klotho Neurosciences Expands Into Mining With Greenland Mines Deal